IQ-AI LTD. LS -01 (F:5Y1) — Market Cap & Net Worth
Market Cap & Net Worth: IQ-AI LTD. LS -01 (5Y1)
IQ-AI LTD. LS -01 (F:5Y1) has a market capitalization of $123.35K (€105.51K) as of September 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #31438 globally and #2803 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IQ-AI LTD. LS -01's stock price €0.00 by its total outstanding shares 246709789 (246.71 Million). Also see 5Y1 asset base for a full breakdown of the balance sheet.
IQ-AI LTD. LS -01 Market Cap History: 2021 to 2026
IQ-AI LTD. LS -01's market capitalization history from 2021 to 2026. Data shows change from $16.73 Million to $144.21K (-61.06% CAGR). Also see cash efficiency ratio of IQ-AI LTD. LS -01 for how efficiently the company converts equity into cash flow.
IQ-AI LTD. LS -01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IQ-AI LTD. LS -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for IQ-AI LTD. LS -01 for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.18x
IQ-AI LTD. LS -01's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $16.73 Million | $521.07K | -$501.06K | 32.11x | N/A |
| 2022 | $3.75 Million | $535.89K | -$511.60K | 7.00x | N/A |
| 2023 | $11.10 Million | $609.39K | -$623.82K | 18.22x | N/A |
| 2024 | $2.16 Million | $750.11K | -$327.10K | 2.88x | N/A |
| 2025 | $144.21K | $788.15K | -$400.94K | 0.18x | N/A |
Competitor Companies of 5Y1 by Market Capitalization
Companies near IQ-AI LTD. LS -01 in the global market cap rankings as of September 18, 2026. Review 5Y1 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to IQ-AI LTD. LS -01 by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #734 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1907 globally with a market cap of $12.22 Billion USD ( AU$17.27 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2071 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2140 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #734 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $264.90 |
| #1907 | Pro Medicus Ltd | AU:PME | $12.22 Billion | AU$165.31 |
| #2071 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $69.97 |
| #2140 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.96 |
IQ-AI LTD. LS -01 Historical Marketcap From 2021 to 2026
Between 2021 and today, IQ-AI LTD. LS -01's market cap moved from $16.73 Million to $ 144.21K, with a yearly change of -61.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €144.21K | 0.00% |
| 2025 | €144.21K | -93.33% |
| 2024 | €2.16 Million | -80.52% |
| 2023 | €11.10 Million | +196.15% |
| 2022 | €3.75 Million | -77.59% |
| 2021 | €16.73 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of IQ-AI LTD. LS -01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $123.35K USD |
| MoneyControl | $123.35K USD |
| MarketWatch | $123.35K USD |
| marketcap.company | $123.35K USD |
| Reuters | $123.35K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IQ-AI LTD. LS -01
Imaging Biometrics Ltd. provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States. It operates through Holding Company, Medical Software, Oral Gallium Maltolate (GaM), and Organ-on-a-Chip segments. The company develops ready-to-use software applications comprising IB Neuro,… Read more